lazabemide has been researched along with Smoking Cessation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubin, HJ; Berlin, I; Lagrue, G; Lancrenon, S; Pedarriosse, AM; Rames, A | 1 |
1 trial(s) available for lazabemide and Smoking Cessation
| Article | Year |
|---|---|
Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Picolinic Acids; Smoking Cessation | 2002 |